Here is a list of the key late-breaking clinical study presentations at the 2019 American Heart Association (AHA) annual meeting, Nov. 16-18, 2019, in Philadelphia.
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congesitive heart failure (CHF). The channel includes news on HFpEF and HFrEF.
-
-
November 6, 2019 — Cleveland Clinic announced the Top 10 Medical Innovations for 2020 at a multimedia presentation last month that capped off...
-
October 21, 2019 – The U.S.
-
October 4, 2019 – Results of a new economic analysis of the COAPT Trial data found that transcatheter mitral valve repair (TMVR) with MitraClip combined with guideline-directed medical therapy (...
Feature | AHA | November 19, 2019 | Dave Fornell, Editor
November 19, 2019 — Here is a list of the key late-breaking clinical study presentations and links to the results at...
News | AHA | November 14, 2019
November 14, 2019 — More than a million Americans face a doubling in their risk of death during or while recovering...
One of the cardiology technologies in the list of top advances in 2019 is Medtronic’s Tyrx Absorbable Antibacterial Envelope using to enclose cardiac implantable electronic devices (CIEDs). It reduced the risk of major infection by 40 percent, and pocket infection by 61 percent, based on data presented at ACC 2019.
News | November 06, 2019
November 6, 2019 — Cleveland Clinic announced the Top 10...
News | Magnetic Resonance Imaging (MRI) | October 21, 2019
October 21, 2019 — Elevated left ventricular mass, known as left-ventricular hypertrophy, is a stronger...
Feature | Heart Failure | October 21, 2019 | Dave Fornell, Editor
October 21, 2019 – The U.S. Food and Drug Administration (FDA) has granted market clearance for AstraZeneca's...
News | Heart Failure | October 16, 2019
October 16, 2019 — Researchers have shown for the first time in preclinical studies that the...
The COAPT Economic Analysis sub-study found it is cost effective to treat heart failure patients who have severe secondary mitral regurgitation with MitraClip to reduce their MR symptoms.
News | Heart Failure | October 04, 2019
October 4, 2019 – Results of a new economic analysis of the COAPT Trial data found that transcatheter mitral valve...
COAPT Trial three-year data show the MitraClip continues to show safety and effectiveness in heart failure patients with secondary mitral reguritation.
News | Heart Failure | October 03, 2019
October 3, 2019 – The three-year results from the...
A MitraClip case underway at the University of Colorado Hospital hybrid cath lab. Left to right are doctors John Carroll, Edward Gill and Dominik Wiktor. (Photos by Dave Fornell)
Blog | University of Colorado Hospital | October 02, 2019
I recently had the opportunity to conduct an onsite visit to the...
News | Heart Failure | September 27, 2019
September 27, 2019 — Ancora Heart Inc. announced results from an interim analysis of...
News | Heart Failure | September 20, 2019
September 20, 2019 — The new Max and Debra Ernst Heart Center at Beaumont Hospital, Royal Oak, Mich., will open Sept...
News | Heart Failure | September 18, 2019
September 18, 2019 — AstraZeneca announced the U.S. Food and Drug Administration (FDA) has granted Fast Track...
The REDUCE LAP HF-II study will combine Corvia Medical's InterAtrial Shunt Device (IASD), pictured here, with physIQ's continuous monitoring platform to evaluate the device's efficacy in patients with heart failure. Image courtesy of Corvia Medical.
News | Heart Failure | September 12, 2019
September 12, 2019 — Corvia Medical has sponsored and is actively enrolling patients in a...
News | Heart Valve Technology | September 11, 2019
September 11, 2019 — Percutaneous reduction of...
Image courtesy of Amazon.com
News | Heart Failure | September 11, 2019
September 11, 2019 — The ever-present devices that seem to track all our moves can be annoying, intrusive or worse,...
